Relzomostat
Relzomostat (Example 18) is a methionyl aminopeptidase 2 (MetAP2) inhibitor. Relzomostat is used for research on obesity and type 2 diabetes.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2081078-92-2
- Formule: C24H36F2N2O5
- Masse moléculaire:470.55
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
MetAp2 |
MetAP2 is an intracellular Mn2+/Co2+-dependent metalloprotease that catalyzes the cleavage of the N-terminal initiating Met from nascent polypeptides and participates in the regulation of endothelial cell proliferation, lipid metabolism, and insulin sensitivity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2081078-92-2
-
Masse moléculaire 470.55
-
Formule C24H36F2N2O5
-
SMILES
C[C@]1([C@H](O1)C/C=C(C)\C)[C@]2([H])[C@]3(CC[C@H]([C@H]2OC)OC(N4CC5(CN(C5)CC(F)F)C4)=O)CO3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)